Your browser doesn't support javascript.
loading
A controlled trial of ambroxol in chronic bronchitis.
Guyatt, G H; Townsend, M; Kazim, F; Newhouse, M T.
Affiliation
  • Guyatt GH; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Chest ; 92(4): 618-20, 1987 Oct.
Article in En | MEDLINE | ID: mdl-3308343
ABSTRACT
Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.
Subject(s)
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Bromhexine / Bronchitis / Expectorants / Ambroxol Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Year: 1987 Type: Article
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Bromhexine / Bronchitis / Expectorants / Ambroxol Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Year: 1987 Type: Article